Developing nations will lobby for research funds for TB, malaria

India and other developing countries are set to lobby hard for funding mechanisms to develop medicines,
mostly aimed at neglected diseases such as tuberculosis and malaria, at a forum set up by the World Health Organization or WHO. Developed countries have long maintained that patents are sufficient incentive for innovation.

India’s first stand alone health insurance company : Anand Roy, AVP Marketing and Sales, STAR Health & Allied Insurance Company Ltd.

Interview

Cellworks in collaboration with Orchid on drug discovery

Cellworks Research India, the Bangalore-based research and development (R&D) wing of Cellworks Group Inc (California-headquartered company), has assisted Chennai-based Orchid Chemicals and Pharmaceuticals by providing system biology technology in carrying out ongoing New Chemical Entity (NCE) research programme.

Insurance sector to get healthier : K. C. Mishra, Director, National Insurance Academy, Pune

IRDA expects the health insurance business to be the second-largest premium earner for insurance companies after motor insurance within the next three years�

Interview

India’s Drug Regulatory Authority to be based on US FDA Model

In the next three years, India would move towards setting up a drug regulatory authority on the model of the US FDA, the country

NRIs’ help sought in state-funded health insurance scheme

The government has sought support from Non-resident Indians (NRIs) for the proposed state-funded health insurance cover scheme that is aimed at helping some 300 million people living below the poverty line (BPL) across India.

Emerging markets are driving new models of care, which can only be achieved through IT : Dr. Brian Cohen, Chief Technology Officer, IBA Health

Interview

SMB hospitals are more challenging than the larger hospitals : Dinesh Samudra, Director and COO, SEED Healthcare Solutions’

SEED Healthcare Solutions� Director and COO, Dinesh Samudra, in conversation with eHEALTH shares his views on the challenges and opportunities of catering to the SMB segment.

Alved Pharma goes to ICICI Ventures for INR 30 cr

Private equity (PE) major ICICI Ventures is acquiring Chennai-based standalone pharmaceutical and
veterinary company Alved Pharma and Foods. RFCL, a wholly-owned veterinary, chemicals and medical
diagnostic company of ICICI Ventures, is learnt to have signed a definitive agreement with Alved Pharma and Foods for a complete buyout.

Standardisation in healthcare delivery will be a major help for smooth IT implementatio : Sandeep Sinha, Industry Manager, Healthcare Practice, Frost & Sullivan

Interview

THERE IS ROOM FOR NICHE INITIATIVES LIKE OURS : Dr. E. S. Rajendran, MD, New Steth Diagnostic Solutions Pvt. Ltd.

Interview

Appropriate use of technology for the benefit of patients is most desirable : Dharminder Nagar, MD, Paras Hospital

Interview